Unknown

Dataset Information

0

Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death.


ABSTRACT: The adapters IRS1 and IRS2 link growth factor receptors to downstream signaling pathways that regulate proliferation and survival. Both suppress factor-withdrawal-induced apoptosis and have been implicated in cancer progression. However, recent studies suggest IRS1 and IRS2 mediate differential functions in cancer pathogenesis. IRS1 promoted breast cancer proliferation, while IRS2 promoted metastasis. The role of IRS1 and IRS2 in controlling cell responses to chemotherapy is unknown. To determine the role of IRS1 and IRS2 in the sensitivity of cells to chemotherapy, we treated 32D cells lacking or expressing IRS proteins with various concentrations of chemotherapeutic agents. We found that expression of IRS1, in contrast to IRS2, enhanced the sensitivity of 32D cells to chemotherapy-induced apoptosis. When IRS2 was expressed with IRS1, the cells no longer showed enhanced sensitivity. Expression of IRS1 did not alter the expression of pro- and anti-apoptotic proteins; however, 32D-IRS1 cells expressed higher levels of Annexin A2. In 32D-IRS1 cells, IRS1 and Annexin A2 were both located in cytoplasmic and membrane fractions. We also found that IRS1 coprecipitated with Annexin A2, while IRS2 did not. Decreasing Annexin A2 levels reduced 32D-IRS1 cell sensitivity to chemotherapy. These results suggest IRS1 enhances sensitivity to chemotherapy in part through Annexin A2.

SUBMITTER: Porter HA 

PROVIDER: S-EPMC3395425 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death.

Porter Holly A HA   Carey Gregory B GB   Keegan Achsah D AD  

Experimental cell research 20120528 14


The adapters IRS1 and IRS2 link growth factor receptors to downstream signaling pathways that regulate proliferation and survival. Both suppress factor-withdrawal-induced apoptosis and have been implicated in cancer progression. However, recent studies suggest IRS1 and IRS2 mediate differential functions in cancer pathogenesis. IRS1 promoted breast cancer proliferation, while IRS2 promoted metastasis. The role of IRS1 and IRS2 in controlling cell responses to chemotherapy is unknown. To determin  ...[more]

Similar Datasets

| S-EPMC3275635 | biostudies-literature
| S-EPMC4761646 | biostudies-literature
| S-EPMC3430578 | biostudies-literature
| S-EPMC8773829 | biostudies-literature
| S-EPMC3160901 | biostudies-literature
| S-EPMC87057 | biostudies-literature
2022-01-13 | GSE162429 | GEO
| S-EPMC5001853 | biostudies-literature
| S-EPMC7308064 | biostudies-literature
2015-01-01 | GSE24613 | GEO